rs2307479

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001135651.3(EIF2AK2):​c.785+72A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0367 in 1,280,648 control chromosomes in the GnomAD database, including 1,243 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.057 ( 397 hom., cov: 32)
Exomes 𝑓: 0.034 ( 846 hom. )

Consequence

EIF2AK2
NM_001135651.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.214

Publications

3 publications found
Variant links:
Genes affected
EIF2AK2 (HGNC:9437): (eukaryotic translation initiation factor 2 alpha kinase 2) The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. The encoded protein plays an important role in the innate immune response against multiple DNA and RNA viruses. [provided by RefSeq, Jul 2021]
EIF2AK2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Illumina, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • early-onset generalized limb-onset dystonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dystonia 33
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2AK2NM_001135651.3 linkc.785+72A>C intron_variant Intron 10 of 16 ENST00000233057.9 NP_001129123.1 P19525-1Q8IW76

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2AK2ENST00000233057.9 linkc.785+72A>C intron_variant Intron 10 of 16 2 NM_001135651.3 ENSP00000233057.4 P19525-1

Frequencies

GnomAD3 genomes
AF:
0.0574
AC:
8729
AN:
152134
Hom.:
394
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.0327
Gnomad ASJ
AF:
0.0285
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0317
Gnomad FIN
AF:
0.0253
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0336
Gnomad OTH
AF:
0.0454
GnomAD4 exome
AF:
0.0339
AC:
38205
AN:
1128396
Hom.:
846
AF XY:
0.0343
AC XY:
19583
AN XY:
571526
show subpopulations
African (AFR)
AF:
0.127
AC:
3162
AN:
24980
American (AMR)
AF:
0.0256
AC:
811
AN:
31670
Ashkenazi Jewish (ASJ)
AF:
0.0318
AC:
672
AN:
21128
East Asian (EAS)
AF:
0.000509
AC:
19
AN:
37320
South Asian (SAS)
AF:
0.0404
AC:
2865
AN:
70834
European-Finnish (FIN)
AF:
0.0244
AC:
1253
AN:
51346
Middle Eastern (MID)
AF:
0.0433
AC:
216
AN:
4994
European-Non Finnish (NFE)
AF:
0.0328
AC:
27445
AN:
837656
Other (OTH)
AF:
0.0364
AC:
1762
AN:
48468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1775
3549
5324
7098
8873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
940
1880
2820
3760
4700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0575
AC:
8754
AN:
152252
Hom.:
397
Cov.:
32
AF XY:
0.0554
AC XY:
4124
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.127
AC:
5266
AN:
41530
American (AMR)
AF:
0.0326
AC:
498
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0285
AC:
99
AN:
3470
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5186
South Asian (SAS)
AF:
0.0317
AC:
153
AN:
4820
European-Finnish (FIN)
AF:
0.0253
AC:
269
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0336
AC:
2284
AN:
68024
Other (OTH)
AF:
0.0445
AC:
94
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
398
796
1193
1591
1989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0411
Hom.:
71
Bravo
AF:
0.0603
Asia WGS
AF:
0.0230
AC:
81
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.0
DANN
Benign
0.77
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307479; hg19: chr2-37362555; API